Literature DB >> 2851962

Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma.

M V Sauer1, M Tomlinson, W Rich.   

Abstract

Hematometra developed in a patient receiving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2851962     DOI： 10.1007/bf00932274

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  4 in total

1.  Treatment and survival in 631 patients with invasive carcinoma of the cervix.

Authors:  C Gad
Journal:  Br J Obstet Gynaecol       Date:  1976-07

2.  Residual carcinoma after intracavitary irradiation of endometrial carcinoma, stage I. A study of whole-organ sections.

Authors:  O Gröntoft; B Risberg; S Sténson; B Westholm
Journal:  Acta Obstet Gynecol Scand       Date:  1982       Impact factor: 3.636

3.  Persistence of endometrial activity after radiation therapy for cervical carcinoma.

Authors:  D Barnhill; P Heller; J Dames; W Hoskins; D Gallup; R Park
Journal:  Obstet Gynecol       Date:  1985-12       Impact factor: 7.661

4.  Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.

Authors:  L Weinstein
Journal:  Obstet Gynecol       Date:  1987-06       Impact factor: 7.661
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.